Applied DNA Sciences

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$797
$929
$891
$779
Gross Profit
245
109
231
78
EBITDA
-3,212
-3,431
-3,490
-4,360
EBIT
-3,346
-3,617
-3,789
-4,690
Net Income
1,879
-4,470
-1,182
-3,592
Net Change In Cash
797
929
891
779
Free Cash Flow
-3,516
-3,224
-3,757
-2,562
Cash
10,442
3,149
3,359
7,151
Basic Shares
4,014
871
683
678

Annual Financials

Values in thousands 2023-09-30 2022-09-30 2021-09-30 2020-09-30
Revenue
$13,367
$18,168
$9,027
$1,931
Gross Profit
5,533
5,053
4,928
1,210
EBITDA
-9,591
-12,679
-11,682
-12,249
EBIT
-10,953
-13,969
-12,526
-12,534
Net Income
-9,947
-8,377
-16,029
-12,764
Net Change In Cash
13,367
18,168
9,027
1,931
Cost of Revenue
7,227
Free Cash Flow
-6,296
-9,466
-15,936
-12,206
Cash
7,151
15,215
6,554
7,786
Basic Shares
653
448
345
195

Earnings Calls

Quarter EPS
2024-06-30
$0.47
2024-03-31
-$5.31
2023-12-31
-$0.09
2023-09-30
-$0.26